These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 15628403)

  • 1. [Amyloid beta peptide].
    Kowa H; Iwatsubo T
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():307-9. PubMed ID: 15628403
    [No Abstract]   [Full Text] [Related]  

  • 2. Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.
    Donohue MC; Gamst AC; Aisen PS
    Alzheimers Dement; 2011 Mar; 7(2):245-6; author reply 247-9. PubMed ID: 21414558
    [No Abstract]   [Full Text] [Related]  

  • 3. Tapping into the biology of Alzheimer disease.
    Knopman DS
    Neurology; 2011 Feb; 76(6):496-7. PubMed ID: 21228299
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.
    Ikeda T; Ono K; Elashoff D; Condron MM; Noguchi-Shinohara M; Yoshita M; Teplow DB; Yamada M
    J Alzheimers Dis; 2010; 21(1):81-6. PubMed ID: 20413863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species.
    Dillen L; Cools W; Vereyken L; Timmerman P
    Bioanalysis; 2011 Jan; 3(1):45-55. PubMed ID: 21175366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sharpen that needle.
    Herskovits AZ; Growdon JH
    Arch Neurol; 2010 Aug; 67(8):918-20. PubMed ID: 20697041
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.
    Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Otto M; Kornhuber J; Rüther E; Wiltfang J
    Dement Geriatr Cogn Disord; 2011; 31(1):37-44. PubMed ID: 21135556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid.
    Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Touchon J; Perret-Liaudet A; Lehmann S
    Brain Res; 2010 Oct; 1357():175-83. PubMed ID: 20713025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination.
    Ivanoiu A; Sindic CJ
    Neurocase; 2005 Feb; 11(1):32-9. PubMed ID: 15804922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluid.
    Schipke CG; Prokop S; Heppner FL; Heuser I; Peters O
    Dement Geriatr Cogn Disord; 2011; 31(2):139-45. PubMed ID: 21304219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory.
    Dumurgier J; Paquet C; Benisty S; Kiffel C; Lidy C; Mouton-Liger F; Chabriat H; Laplanche JL; Hugon J
    Neurobiol Dis; 2010 Nov; 40(2):456-9. PubMed ID: 20656030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What does it mean to be 'amyloid-positive'?
    Fagan AM
    Brain; 2015 Mar; 138(Pt 3):514-6. PubMed ID: 25713403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer's disease.
    Shi JQ; Wang BR; Jiang WW; Chen J; Zhu YW; Zhong LL; Zhang YD; Xu J
    J Am Geriatr Soc; 2011 Jun; 59(6):1142-4. PubMed ID: 21668921
    [No Abstract]   [Full Text] [Related]  

  • 14. Could clinical profile influence CSF biomarkers in early-onset Alzheimer disease?
    Koric L; Felician O; Guedj E; Hubert AM; Mancini J; Boucraut J; Ceccaldi M
    Alzheimer Dis Assoc Disord; 2010; 24(3):278-83. PubMed ID: 20473135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid biomarkers: pushing the limits of early detection.
    Rabinovici GD
    Brain; 2016 Apr; 139(Pt 4):1008-10. PubMed ID: 27012491
    [No Abstract]   [Full Text] [Related]  

  • 16. Alzheimer disease: chaperone protein clusterin is involved in amyloid-β-associated entorhinal atrophy in early AD.
    Malkki H
    Nat Rev Neurol; 2014 Feb; 10(2):60. PubMed ID: 24445801
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype.
    Popp J; Lewczuk P; Frommann I; Kölsch H; Kornhuber J; Maier W; Jessen F
    J Alzheimers Dis; 2010; 22(2):459-68. PubMed ID: 21084733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report.
    DiFrancesco JC; Brioschi M; Brighina L; Ruffmann C; Saracchi E; Costantino G; Galimberti G; Conti E; Curtò NA; Marzorati L; Remida P; Tagliavini F; Savoiardo M; Ferrarese C
    Neurology; 2011 Mar; 76(9):842-4. PubMed ID: 21357837
    [No Abstract]   [Full Text] [Related]  

  • 19. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.
    Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
    J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added diagnostic value of CSF biomarkers in differential dementia diagnosis.
    Le Bastard N; Martin JJ; Vanmechelen E; Vanderstichele H; De Deyn PP; Engelborghs S
    Neurobiol Aging; 2010 Nov; 31(11):1867-76. PubMed ID: 19150153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.